Answer
Yes, hyperkalaemia is listed as a common possible adverse reaction to dalteparin sodium; heparin products can increase potassium through hypoaldosteronism, although clinically significant hyperkalaemia occurs rarely, particularly in patients with chronic renal failure and diabetes mellitus.
Sources for this answer
- Fragmin 12,500 IU/0.5ml solution for injectionPfizer Limited · emc · SmPC §4.8 Undesirable effects · Version 13Document updated
Sources checked